Hera-MI focuses its research on artificial intelligence applied to medical imaging, with a particular emphasis on cancer diagnosis.
The company’s objective is to address the future healthcare challenges by enhancing the healthcare system experience through AI.
In this context, Hera-MI is developing software solutions to support medical decision-making, benefiting radiologists, breast specialists, and patients.
In this regard, Hera-MI has introduced a pioneering medical device, Breast-SlimView®. This is a patented decision support software dedicated to 2D and 3D mammography (tomosynthesis), specifically designed for breast cancer diagnostic.
Breast Cancer
Artificial Intelligence
Mammography
Transform your diagnostic approach with our AI solution, providing enhanced security and unparalleled ease of use.
Free yourselves from irrelevant information
and detect suspicious areas at a glance
Breast-SlimView® offers an innovative reading support that stands out by presenting only relevant information.
A patented clinical decision solution
for 2D and 3D mammography
A faster and improved breast cancer diagnosis
You wish to stay up to date on Hera-MI & BSV? Don’t miss our latest news & subscribe to our newsletter!
